1. Analysis of Short- and Long-term Outcomes of Patients With Surgically Treated Left-sided Infective Endocarditis: A 5-Year Longitudinal Follow-up Study
- Author
-
Brett Hiebert, Oksana Marushchak, Holy Cole, Rakesh C. Arora, Pallav Shah, Evelyn Lo, James W. Tam, Nasir Shaikh, Alan H. Menkis, and Yoav Keynan
- Subjects
Adult ,Male ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Prosthesis-Related Infections ,Time Factors ,Databases, Factual ,Kaplan-Meier Estimate ,030204 cardiovascular system & hematology ,Patient Readmission ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,Risk Factors ,Long term outcomes ,Left sided infective endocarditis ,Humans ,Medicine ,Endocarditis ,Hospital Mortality ,Longitudinal Studies ,Aged ,Proportional Hazards Models ,Retrospective Studies ,Heart Valve Prosthesis Implantation ,Culture-negative endocarditis ,Native Valve Endocarditis ,biology ,business.industry ,Follow up studies ,Manitoba ,Endocarditis, Bacterial ,General Medicine ,Middle Aged ,medicine.disease ,biology.organism_classification ,Surgery ,Logistic Models ,Treatment Outcome ,030228 respiratory system ,Viridans streptococci ,Heart Valve Prosthesis ,Infective endocarditis ,Multivariate Analysis ,Female ,Cardiology and Cardiovascular Medicine ,business ,Follow-Up Studies - Abstract
This study aims to analyze survival, repeat hospitalization, and risk factors for surgically treated left-sided endocarditis. Retrospective review of all 166 (114 native and 52 prosthetic) patients operated between January 2004 and March 2015 was performed. Long-term survival and repeat hospitalization data for 134 of 166 patients were obtained via linked clinical databases with the Manitoba Centre for Health Policy. Kaplan-Meier estimates of survival and hospital readmission and Cox multivariable regression analysis of factors influencing outcomes were performed. Survival at 1 and 5 years was 91% and 80%, respectively, and major adverse prosthesis-related event repeat hospitalization rates were 12% and 21%, respectively. Repeat hospitalization because of endocarditis was 7% and 11% at 1 and 5 years, respectively. Survival and repeat hospitalization were similar for aortic and mitral valves. Survival after surgically treated endocarditis was similar to survival for age-, sex-, and valve-matched surgical valve replacements for noninfectious indications (P = 0.53). Viridans Streptococci was the most common organism in native valve endocarditis, and culture negative endocarditis was most common in prosthetic valves. Prosthetic valve endocarditis (P 0.01) and preoperative renal dysfunction (P 0.01) were risk factors for in-hospital mortality and major postoperative adverse events. Diabetes and renal dysfunction were associated with poor long-term survival, functional survival, and repeat hospitalization. This analysis suggests that surgery remains a very effective tool in management of these complex patients in terms of survival and major adverse prosthesis-related event repeat hospitalization.
- Published
- 2017